期刊
INNATE IMMUNITY
卷 19, 期 1, 页码 76-85出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1753425912453187
关键词
ADCC; cetuximab; colorectal cancer; immune suppression; natural killer cells
资金
- Fundacion Sales
- Fundacion P. Mosoteguy
- Fundacion Cancer (FUCA)
- Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)
- Fundacion Maria Calderon de la Barca, Argentina
Despite NK cells being originally identified because of their ability to kill tumor cells in vitro, only limited information is available on NK cells infiltration of malignant tumors, especially in humans. NK cells infiltrating human colorectal carcinomas (CRCs) were analyzed to identify their potential protective role in an antitumor immune response. The expression and function of relevant molecules were analyzed from different sources, comparing tumor-associated NK cells (TANKs) with autologous peripheral blood NK cells (PB-NKs) from CRC patients-the latter in comparison with PB-NKs from normal donors. TANKs displayed a profound alteration of their phenotype with a drastic reduction of NK cell receptor expression. Co-culture experiments showed that CRC cells produce modulation in NK phenotype and functionality. Moreover, PB-NKs from CRC patients also exhibited an altered phenotype and profound defects in the ability to activate degranulation and IFN-gamma production. For the first time, TANK and PB-NK cells from CRC patients have been characterized. It is shown that they are not capable of producing relevant cytokines and degranulate. Taken together, our results suggest that NK cells from CRC patients present alterations of phenotype and function therefore supporting the progression of cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据